YY/T 1213-2013Follicle stimulating hormone quantitative labelling immunoassay kit (English PDF)
促卵泡生成素定量标记免疫分析试剂盒
This is a limited preview
Buy now to download the full PDF (15 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1213-2013 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
October 21, 2013
Implementation date
October 1, 2014
Scope
YY/T 1213-2013 is the English-translated version of 促卵泡生成素定量标记免疫分析试剂盒.
YY/T 1213-2013 is the Chinese standard "Follicle stimulating hormone quantitative labelling immunoassay kit".
Its scope clause reads: This standard specifies the classification, requirements, test method, marks, labels, instructions, packaging, transportation and storage etc. of the follicle stimulating hormone quantitative labelling immunoassay kit.
This standard is applicable to follicle stimulating hormone (FSH) kit [herein after referred to as “FSH kit”] that is quantitatively determined and based on the principle of double antibody sandwich method.
It includes the FSH immunoassay kit of quantitative determination by using enzyme labelling, (electrical) chemiluminescent labelling, (time resolution) fluorescence labelling and other labelling methods as the capture antibodies; and taking micro-plates, tubes, magnetic particles, micro-beads and plastic beads and others as the carrier coated antibodies.
This standard does not apply to. a) Colloidal gold labeled FSH test strip; b) Various types of FSH radio-immunity or IRMA kit labeled with 125I and other radioactive isotopes.
Its clauses include classification; marks, labels and instructions; packaging, transportation and storage; ye yingwu; chinese pharmacopoeia commission; chinese pharmacopoeia commission; guo zuchao.
Found what you need?
Document preview — YY/T 1213-2013
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- 1 Scope4
- 2 Normative references4
- 3 Classification4
- 4 Requirements5
- 5 Test methods6
- 6 Marks, labels and instructions8
- 7 Packaging, transportation and storage10
- Bibliography11
1 Scope
This standard specifies the classification, requirements, test method, marks, labels, instructions, packaging, transportation and storage etc. of the follicle stimulating hormone quantitative labelling immunoassay kit.
This standard is applicable to follicle stimulating hormone (FSH) kit [herein after referred to as “FSH kit”] that is quantitatively determined and based on the principle of double antibody sandwich method. It includes the FSH immunoassay kit of quantitative determination by using enzyme labelling, (electrical) chemiluminescent labelling, (time resolution) fluorescence labelling and other labelling methods as the capture antibodies;
and taking micro-plates, tubes, magnetic particles, micro-beads and plastic beads and others as the carrier coated antibodies.
This standard does not apply to.
a) Colloidal gold labeled FSH test strip;
b) Various types of FSH radio-immunity or IRMA kit labeled with 125I and other radioactive isotopes.
2 Normative references
The articles contained in the following documents have become part of this document when they are quoted herein. For the dated documents so quoted, all the modifications (Including all corrections) or revisions made thereafter shall be applicable to this document.
YY/T 0466.1 Devices - Symbols to be used with medical device labels, labelling and information to be supplied - Part 1.General requirements
3 Classification
The FSH kits can be classified into enzyme labelling FSH kit, (electrical) chemiluminescent labelling FSH kit, (time resolution) fluorescence labelling FSH kit etc., according to the various labelling methods. It can also be divided into different kinds of
FSH kits taking micro-plates, pipes, magnetic particles, micro-beads and plastic beads as carrier, according to the various solid phase carriers. It can be divided into manual
CV - Coefficient of variation.
5.5.2 Analytical within-precision
Two or three quality control products are set up in different areas of dose-response curves.
The coefficient of variation (CV) of measured value of quality control products shall be in accordance with the provisions of 4.5.2 among independent analysis with no less than 3 times. The calculation method is same as 5.5.1.
Note. Independent analyses includes. Among different independent experiments, among different time periods within the period of validity of the kit, among different laboratories with the same kit and among different operators, etc.
5.5.3 Within-batch precision
Two or three quality control products are set up in different areas of dose-response curves.
The coefficient of variation (CV) of measured value of quality control products shall be in accordance with the provisions of Clause 4.5.2 among at least 3 batches of products. The calculation method is same as 5.5.1.
5.6 The measured value of quality control products
Two or three quality control products are set up in different areas of dose-response curves.
The measured results of the kit shall be in accordance with the provisions of Clause 4.6.
5.7 Specificity
The sample with specificity shall be prepared to a prescribed concentration by using the kit buffer system. The measured results of the kit shall be in accordance with the provisions of 4.7.1, 4.7.2 and 4.7.3.
5.8 Stability
After the kit is preserved according to the provisions of Clause 4.8.1 or 4.8.2, the measured results shall be in accordance with related provisions of Clause 4.1, 4.2, 4.3,
4.4, 4.5.1, 4.5.2 and 4.6.
6 Marks, labels and instructions
6.1 Outer package of kit
It shall be in compliance with the requirements of YY/T0466.1, and at least contains the following content.
a) Product name, specification;
b) Name, address and contact information of manufacturers;
m) Product performance index;
n) Precautions;
o) References;
p) Manufacturing enterprise;
q) License number of medical device manufacturers (limited to domestic enterprises);
r) Medical Device Registration Certificate Number;
s) Product standard number;
t) Approval and modified date of instructions.
7 Packaging, transportation and storage
7.1 Package
Intact, free of leakage and damage.
7.2 Transportation
The transportation of the kit shall be in compliance with the requirement of the manufacturer.
7.3 Storage
The kit shall be kept under the conditions specified by the manufacturer.
Bibliography
1.GB/T 3358.1 Statistics - Vocabulary and symbols - Part 1.General statistical terms and terms used in probability
2 JJF 1001-2011 General Terms in Metrology and Their Definitions
3 Ye Yingwu
National clinical laboratory operation specification. Edition 3.Nanjing.
Southeast Press, 2006
4.YY/T 0316-2008 Medical devices - Application of risk management to medical devices (ISO 14971.2007, IDT)
5 Chinese Pharmacopoeia Commission
General principles of Radioimmunoassay Kit.
6 Chinese Pharmacopoeia Commission
Chinese Requirements for Biological Products (2000)
7 Guo Zuchao
Statistical Methods for Medical Use, Edition 3.Beijing. People Health
Press, 1988
YY/T 1206-2013 | YY/T 1218-2013 | YY/T 1214-2013 | YY/T 1204-2021 | […]
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 15 pages — is available in the English PDF.
Similar standards
How to Download YY/T 1213-2013
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Fast delivery
After payment you'll receive an email confirmation. The English PDF is sent to the same address, usually within minutes and at the latest within 1 business day.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0463-2026 — Dentistry - Refractory investment and die materials
YY/T 0479-2026 — Medical diagnostic X-ray tube assemblies and X-ray source assemblies - Determination of maximum symmetric radiation field
YY/T 1213-2013
$135.00